TY - JOUR
T1 - Specialization of actin isoforms derived from the loss of key interactions with regulatory factors
AU - Boiero Sanders, Micaela
AU - Toret, Christopher P.
AU - Guillotin, Audrey
AU - Antkowiak, Adrien
AU - Vannier, Thomas
AU - Robinson, Robert C.
AU - Michelot, Alphée
N1 - Funding Information:
The authors thank Isabelle Sagot and Emilia Mauriello for their invaluable advice on the project; Sarah Würbel and Ahmed Fatmi for their technical help. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement n° 638376/Segregactin) to A.M., from the Labex INFORM (ANR‐11‐LABX‐0054, funded by the “Investissements d’Avenir French Government program”), and from the Fondation pour la Recherche Médicale (FRM) to M.B.S. under the program Fin de thèse (ref. FDT201904008021). R.C.R. thanks Vidyasirimedhi Institute of Science and Technology (VISTEC), RIIS and JSPS (KAKENHI grant number JP20H00476) for support. We acknowledge the France‐BioImaging infrastructure supported by the Agence Nationale de la Recherche (ANR‐10‐INSB‐04‐01). Sequencing was performed by the GenomEast platform, a member of the “France Génomique” consortium (ANR‐10‐INSB‐0009).
Publisher Copyright:
© 2022 The Authors. Published under the terms of the CC BY NC ND 4.0 license
PY - 2022/3/1
Y1 - 2022/3/1
N2 - A paradox of eukaryotic cells is that while some species assemble a complex actin cytoskeleton from a single ortholog, other species utilize a greater diversity of actin isoforms. The physiological consequences of using different actin isoforms, and the molecular mechanisms by which highly conserved actin isoforms are segregated into distinct networks, are poorly known. Here, we sought to understand how a simple biological system, composed of a unique actin and a limited set of actin-binding proteins, reacts to a switch to heterologous actin expression. Using yeast as a model system and biomimetic assays, we show that such perturbation causes drastic reorganization of the actin cytoskeleton. Our results indicate that defective interaction of a heterologous actin for important regulators of actin assembly limits certain actin assembly pathways while reinforcing others. Expression of two heterologous actin variants, each specialized in assembling a different network, rescues cytoskeletal organization and confers resistance to external perturbation. Hence, while species using a unique actin have homeostatic actin networks, actin assembly pathways in species using several actin isoforms may act more independently.
AB - A paradox of eukaryotic cells is that while some species assemble a complex actin cytoskeleton from a single ortholog, other species utilize a greater diversity of actin isoforms. The physiological consequences of using different actin isoforms, and the molecular mechanisms by which highly conserved actin isoforms are segregated into distinct networks, are poorly known. Here, we sought to understand how a simple biological system, composed of a unique actin and a limited set of actin-binding proteins, reacts to a switch to heterologous actin expression. Using yeast as a model system and biomimetic assays, we show that such perturbation causes drastic reorganization of the actin cytoskeleton. Our results indicate that defective interaction of a heterologous actin for important regulators of actin assembly limits certain actin assembly pathways while reinforcing others. Expression of two heterologous actin variants, each specialized in assembling a different network, rescues cytoskeletal organization and confers resistance to external perturbation. Hence, while species using a unique actin have homeostatic actin networks, actin assembly pathways in species using several actin isoforms may act more independently.
KW - actin cytoskeleton
KW - actin isoforms
KW - actin-binding proteins
KW - biomimetism
KW - Saccharomyces cerevisiae
UR - http://www.scopus.com/inward/record.url?scp=85124723016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124723016&partnerID=8YFLogxK
U2 - 10.15252/embj.2021107982
DO - 10.15252/embj.2021107982
M3 - Article
C2 - 35178724
AN - SCOPUS:85124723016
SN - 0261-4189
VL - 41
JO - EMBO Journal
JF - EMBO Journal
IS - 5
M1 - e107982
ER -